Trial Profile
A Phase II / III, prospective, randomised, active-controlled, open label, Parallel group, 2-arm, Multi-centric trial for evaluation of Efficacy, Safety, and Tolerability of DTaP plus Hib (Diphtheria, acellular Pertussis, Tetanus and Hemophilus influenza b) combination vaccine in Indian paediatric population in comparison with Pentaxim (Diphtheria, acellular Pertussis, Tetanus, Hemophilus influenza b and IPV) combination vaccine of Sanofi Pasteur
Status:
Suspended
Phase of Trial:
Phase II/III
Latest Information Update: 04 Apr 2019
Price :
$35
*
At a glance
- Drugs DTP-Haemophilus-influenza-B-vaccine-Wockhardt (Primary)
- Indications Diphtheria; Haemophilus infections; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Wockhardt Ltd
- 26 Mar 2019 Status changed from not yet recruiting to suspended.
- 05 Jan 2018 New trial record